Skip to content

Does microbial composition and fermentative capacity differ between stool samples collected from male adults of different ages?

Does faecal microbial composition and fermentative capacity differ between male adults of different ages?

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625001178437
Enrollment
24
Registered
2025-10-29
Start date
2025-11-03
Completion date
2026-04-30
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The in vitro colonic fermentation assay mimics the microbe (bacterial) large intestine functions and can be used to evaluate the metabolites produced during colonic fermentation. The quantity of a wide range of metabolites, eg butyric acid (considered beneficial) and putric acid (deemed as damaging) that are produced can be determined. Faecal samples are collected from healthy humans to provide the microbiota needed for the fermentation assay. There is evidence that with aging, the faecal microbiota composition changes, but little information is available on this. We seek to understand whether the fermentative capacity of faecal samples collected from males within different age groups differs; thus whether age needs to be considered to simulate colonic functions in vitro.

Interventions

Males will be recruited from 3 age ranges: young (18-25 y), middle (40-50 y), and older (65-75 y) with n = 8 participants in each of the 3 groups. They will all be provided with the same meals (breakfast, lunch, dinner and snacks) for a 10 day period (days 1 to 10; microbial adaptation period). Lunch and dinner are being prepared by a commercial meal provider. With meals and snacks the participants will receive 2132-2230 calories, 82-94 g protein, 33-37 g fibre daily. Participants will also

Males will be recruited from 3 age ranges: young (18-25 y), middle (40-50 y), and older (65-75 y) with n = 8 participants in each of the 3 groups. They will all be provided with the same meals (breakfast, lunch, dinner and snacks) for a 10 day period (days 1 to 10; microbial adaptation period). Lunch and dinner are being prepared by a commercial meal provider. With meals and snacks the participants will receive 2132-2230 calories, 82-94 g protein, 33-37 g fibre daily. Participants will also receive a commercial multivitamin tablet to take each day of this 10 day period containing Retinol acetate (vitamin A) 300 micrograms R.E.; Betacarotene 900 micrograms; Colecalciferol (vitamin D3) 20 micrograms; Phytomenadione (vitamin K1) 25 micrograms; Calcium pantothenate 13.6 mg; Thiamine nitrate (vitamin B1) 4.6 mg; Nicotinamide 16 mg; Riboflavin (vitamin B2) 4.6 mg; Pyridoxine hydrochloride (vitamin B6) 6.7 mg; Cyanocobalamin (vitamin B12) 21.6 micrograms; Biotin (vitamin H) 54 micrograms; Folic acid 300 micrograms; dl-alpha-tocopheryl acetate (vitamin E) 40 mg; Ascorbic acid (vitamin C) 180 mg; Calcium (294mg as calcium carbonate and 6mg as calcium hydrogen phosphate) 300 mg; Magnesium (as magnesium oxide) 84 mg; Iron (as ferrous fumarate) 6 mg; Zinc (as zinc oxide) 11 mg; Manganese (as manganese sulfate monohydrate) 5.5 mg; Chromium (as chromic chloride hexahydrate) 35 micrograms; Selenium (as sodium selenate) 55 micrograms; Copper (as cupric sulfate) 900 micrograms; Iodine (as potassium iodide) 150 micrograms). The diet has been designed by nutritionists with >20 years' experience and meet all nutritional requirements. Participants will keep a food diary during the 10 day adaptation period to confirm what was consumed. On days 1 and 11, a faecal sample will be collected from each participant for individual microbial analysis and to prepare a pooled inoculum for each age group. Samples will be self-collected using at the participant's home or at our facilities. Participants will receive detailed instructions on how to safely and hygienically collect faecal samples using a standardised protocol. All samples will be collected within a few hours and processed. The inoculum produced from the faecal samples is for use in an in vitro fermentation assay which mimics colonic functioning and requires the processing of fresh faeces to ensure viable microbes for the inoculum. The composition and function of the faecal microbiome for each age group will be determined using shotgun metagenomic sequencing. The faecal samples collected on day 1 for each participant will be compared with those collected on day 11, to determine the typical variation in fermentative capacity. The samples collected on day 11 will give information on the effect of age on fermentative capacity, as with the identical diets (days 1-10), the effect of diet should be minimised. After the pooled inocula is prepared from faecal samples collected from participants in each age group, to compare the fermentative capacity of the faecal inocula across age groups, purified fibre sources with different structures (e.g., cellulose, pectin, resistant starch) will be fermented using the pooled inoculum from each age group with the in vitro colonic fermentation assay. Organic matter (OM) disappearance and microbial metabolites (e.g., organic acids) will be measured by combining HPLC and MS-based methods. The results will be compared between age groups to determine whether there is an effect of age on the microbial action (i.e., fermentative capacity). This will inform as to whether, in the future, we need to consider age as a factor for our assay.

Sponsors

Dr Suzanne Hodgkinson, Massey University
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

• Within the age groups 18-25 years old, 40-50 years old or 65-75 years old • In good general health

Exclusion criteria

Smoke/vape/be a recreational user of illegal substances • Have a thyroid disorder • Have a liver disorder • Have a kidney disorder • Have a diet related illness (e.g., diabetes) • Have a gastrointestinal disorder, and/or have had gastrointestinal surgery • Have a history of or have digestive or bowel problems • Be on a bodyweight loss/gain programme • Take medication that could affect their microbiota (e.g., laxatives, antibiotics) within the last 3 months • Have suffered from gastrointestinal infection within the last 3 months

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026